Pomerantz and Rosen said they are probing potential investor claims after a Financial Times report on Anthropic’s Claude allegations and, in Pomerantz’s notice, a later DOJ non-prosecution agreement.
Pomerantz LLP and Rosen Law Firm said they are investigating potential securities claims involving Alibaba Group Holding Limited. Both notices cite a June 24, 2026 Financial Times report that Anthropic accused Alibaba of obtaining illicit access to Claude by creating fake accounts to use the AI model, which Anthropic does not offer to Chinese groups. Pomerantz also cited a July 1, 2026 U.S. Department of Justice announcement that Alibaba entered a non-prosecution agreement and agreed to pay $600 million to resolve allegations it failed to prevent merchants from selling and importing illegal pharmaceuticals, controlled substances, listed chemicals, and pill presses into the United States through its e-commerce platforms. The firms said Alibaba’s U.S.-traded shares fell after the disclosures, though their notices used different share terminology and cited different price moves for the June 24 report.